A client sits across from you—or on your screen, if you're working virtually—and brings up something new. They've been reading about psilocybin therapy. They've heard about the research. They're curious whether it might help them.

If you're like many therapists I've spoken with, this moment prompts a mix of reactions. Interest, perhaps. Uncertainty about what to say. Questions about what your role should be if they decide to pursue it. Maybe some concern about whether this is a distraction from the work you're doing together, or whether it could actually complement it.

I'm a licensed psilocybin facilitator in Oregon, where psilocybin services became legal in 2023. I also work as a life coach, and I collaborate regularly with therapists whose clients come to me for facilitation. I've seen this dynamic from multiple angles—as someone who facilitates journeys, and as someone who works with clients before and after those journeys in a non-clinical capacity.

What I want to offer here is a practical overview: what the research actually says, why your role as the therapist matters more than you might think, specific ways you can support your client if they pursue this path, and how collaboration with a facilitator can work.

What the Research Says

Let me be direct: the research on psilocybin for depression and anxiety is genuinely promising. This isn't hype. Multiple randomized controlled trials have demonstrated significant reductions in depressive symptoms, with effect sizes that compare favorably to—and in some cases exceed—conventional antidepressants.

A 2023 meta-analysis pooling data from clinical trials found large effect sizes favoring psilocybin over controls for depression treatment. Studies at Johns Hopkins, Imperial College London, and other institutions have shown rapid and sustained improvements in patients with major depressive disorder, including treatment-resistant depression. The FDA has granted "breakthrough therapy" designation to psilocybin for both treatment-resistant depression and major depressive disorder, a status reserved for treatments that may demonstrate substantial improvement over existing options.

The safety profile, when proper screening and support are in place, is reassuring. Common acute effects include nausea and transient increases in blood pressure and heart rate. Psychological distress can occur during sessions, but serious adverse events are rare in supervised settings with appropriate preparation. The most significant risks involve contraindicated conditions (psychotic disorders, certain cardiac conditions) and medication interactions (particularly with serotonergic medications), which is why thorough screening matters.

Beyond depression, research has shown promise for anxiety associated with life-threatening illness, alcohol use disorder, and tobacco addiction. The breadth of conditions responding to a similar intervention suggests something important about the mechanism—psilocybin appears to work not by targeting a specific symptom but by creating conditions in which psychological change becomes more possible.

The Psilocybin Isn't the Cure

Here's what I want therapists to understand most clearly: the psilocybin is not the cure. It's the assist.

Research consistently identifies three factors that predict outcomes: set (the psychological state and expectations the person brings), setting (the physical and interpersonal environment), and integration (what happens afterward). The pharmacology matters, but it doesn't work in isolation.

One of the most compelling findings comes from a Johns Hopkins study examining therapeutic alliance in psilocybin-assisted therapy. Researchers found that the strength of the relationship between participant and therapist predicted the quality of the psychedelic experience, which in turn predicted clinical outcomes. A stronger alliance before psilocybin sessions correlated with deeper mystical experiences and greater psychological insight. The alliance one week after the final session predicted depression scores at four weeks, three months, six months, and twelve months.

This isn't surprising if you think about what psilocybin actually does. It appears to temporarily reduce activity in the Default Mode Network—the brain regions associated with self-referential thinking, rumination, and the maintenance of habitual mental patterns. This creates a window of increased plasticity, both neurologically and psychologically. What someone does with that window matters enormously.

A powerful experience followed by a return to familiar environments, familiar relationships, and familiar patterns of thinking often leads to familiar outcomes. The insights fade. The old grooves reassert themselves. But a powerful experience followed by skilled therapeutic support—someone who can help make sense of what emerged, connect it to ongoing work, and support the translation of insight into action—has a much better chance of producing lasting change.

This is where you come in.

Your Role in Preparation

If your client is preparing for a psilocybin journey, there's meaningful work you can do before they ever take the medicine.

The preparation period—typically one to three weeks before the session—is about surfacing what's already moving beneath the surface. What is your client bringing to this experience? What questions are they holding? What patterns have they been stuck in? What do they hope to understand or release?

This material often emerges naturally in therapy. You may have been working on it for months or years. The preparation period is an opportunity to bring it into sharper focus.

Some specific considerations:

Clarifying intention without rigidifying expectation. Clients benefit from having a sense of what they're bringing to the journey—not a specific outcome they're demanding, but an orientation, a direction they're facing. "I want to understand my relationship with my father" is different from "I want to forgive my father." The first opens inquiry; the second can become a performance standard that interferes with surrender.

Identifying material that may surface. Psilocybin can bring forward memories, emotions, and perspectives that weren't previously accessible. If your client has trauma history, it may emerge. If they've been avoiding something, it may appear. You don't need to predict what will happen, but you can help them prepare for the possibility that difficult material will arise—and normalize that this is often part of the therapeutic process, not a sign that something went wrong.

Supporting realistic expectations. Media coverage of psychedelics tends toward the dramatic—stories of single-session transformations, lifelong depression lifting, mystical experiences that changed everything. These outcomes do occur, but they're not universal. Some journeys are more subtle. Some are challenging without feeling immediately meaningful. Some clients experience relief that fades over time. Helping your client hold appropriate expectations protects against both the inflation of pre-journey fantasy and the deflation of post-journey disappointment.

Reinforcing the skills they'll need. If you work within a framework that emphasizes present-moment awareness, acceptance of difficult experience, or non-attachment to thoughts—Acceptance and Commitment Therapy, mindfulness-based approaches, or similar—your client already has resources that directly apply to navigating a psilocybin experience. The capacity to notice what's arising without immediately reacting, to make room for discomfort rather than fighting it, to observe thoughts as thoughts rather than facts: these are exactly the skills that support surrender during a journey.

Your Role in Integration

Integration is where the real therapeutic work happens. And for clients with an existing therapeutic relationship, you may be the primary integration support.

The first two weeks after a psilocybin journey appear to be particularly important. Research suggests that psilocybin promotes structural neuroplasticity—increased dendritic spine density visible within 24 hours—that persists for at least a month. Whether or not this creates a literal "window" during which change is easier to consolidate, the post-journey period is empirically important for outcomes.

Several features of integration work are worth noting:

The experience continues to unfold. Clients often report that the meaning of their journey becomes clearer over days and weeks, not hours. Don't rush toward interpretation or closure. Create space for the experience to reveal itself gradually. Sometimes the most important insight arrives a week later, during a walk or a shower or a therapy session when something clicks into place.

Clients need to tell and retell the story. Part of integration is narrative—making sense of what happened, finding language for experiences that may resist language. Your client may need to describe the journey multiple times, each telling revealing something new. This isn't repetition; it's processing.

The gap between insight and action can be frustrating. Many clients emerge from journeys with clarity about what they want to change. Then they encounter the challenge of actually changing it. Old patterns reassert themselves. The familiar environment pulls for familiar responses. Part of integration is supporting the translation of insight into committed action—and normalizing that this is hard, ongoing work rather than something that happens automatically.

Challenging experiences can be therapeutically valuable. Not every journey is blissful. Some involve difficulty, fear, grief, or confrontation with painful material. These experiences aren't failures. When properly supported and integrated, they often prove more valuable than easy journeys. Your role is to help your client work with whatever emerged, not to assess whether the experience was "good."

Watch for spiritual bypass. Occasionally, clients use transcendent experiences to sidestep difficult psychological work—"I've realized none of it matters" as a way of avoiding grief, or "I feel completely transformed" while the same patterns persist in relationships. You know your client. You'll be better positioned than anyone to notice if the journey is being used to avoid rather than engage.

Working in a Legal Framework

Oregon was the first state to establish a legal framework for psilocybin services, with Colorado now also serving clients and New Mexico recently passing legislation that will make services available soon. If your client is pursuing a legal journey in Oregon, they'll be working with a licensed facilitator at a licensed service center, using psilocybin produced by a licensed manufacturer and tested in a licensed laboratory. The regulatory framework includes training requirements, safety protocols, and ongoing oversight.

In Oregon, facilitators can now hold dual licensure as both facilitators and therapists. However, during the journey itself, best practice remains non-directive—we don't guide the experience, interpret what's happening, or tell clients what things mean. That's their work, and often, their therapist's work. The therapeutic relationship and clinical expertise become most relevant in the preparation and integration phases.

This distinction creates an opportunity for collaboration. The facilitator handles the journey itself; you handle the ongoing therapeutic relationship. These aren't competing roles—they're complementary.

How Collaboration Can Work

I welcome collaboration with therapists whose clients come to me for facilitation. Here's what that typically looks like:

Before the journey: With the client's consent, I'm happy to connect with you to share information about the protocol and hear any clinical context that would inform my work. This might be a brief call or an exchange of written information. You don't need to know the details of facilitation, but understanding the general structure can help you prepare your client. I use a psychological flexibility framework drawn from ACT and explain psilocybin's effects in terms of the Default Mode Network—your client will come back with these concepts fresh in mind.

After the journey: With the client's consent, I provide a summary to the therapist: the general character of the experience, themes or material that emerged, areas the client wants to explore in therapy, and any observations that might be useful. This isn't a clinical assessment—I'm not doing therapy—but it's a handoff, giving you context for the work ahead.

During integration: I remain available for questions. If something comes up in your sessions that I could illuminate, or if you observe something concerning that I should know about, please reach out. I see my role as complementary to yours, not competitive with it.

Some therapists are deeply familiar with psychedelic work; others are curious but inexperienced; some are frankly skeptical. All of these are workable. What matters is clear communication and a shared commitment to the client's wellbeing.

When Concerns Arise

A few situations warrant particular attention:

Major decisions during integration. Some clients feel moved to make significant life changes immediately after a journey—ending relationships, quitting jobs, moving across the country. The heightened emotional intensity of integration can lead to impulsive choices that don't hold up once ordinary cognition returns. I generally advise clients to wait at least two weeks before acting on major decisions. You may need to help them slow down.

Prolonged destabilization. Rarely, clients experience difficulty that persists beyond the normal integration period. If your client remains significantly destabilized after several weeks, or if you observe symptoms that concern you, don't hesitate to reach out to the facilitator or to additional clinical resources. Most integration challenges resolve with support, but some require more intensive intervention.

Medication considerations. Psilocybin interacts with serotonergic medications, including SSRIs and MAOIs. Clients typically need to taper or discontinue these medications before a journey, which should be done under medical supervision. Be prepared to support your client through this process and watch for destabilization during the taper period.

The Bigger Picture

Psilocybin isn't a magic bullet. It's a tool—one that can create conditions for change but doesn't guarantee it. The research is promising, but it's also early. We don't yet have long-term data on durability of effects or on what factors predict who benefits most. Phase 3 trials are underway, and the picture will continue to clarify.

What we do know is that context matters enormously. The relationship between client and provider—whether facilitator, therapist, or both—shapes outcomes. Preparation and integration matter. The work doesn't end when the journey ends; in many ways, it begins there.

If your client is interested in pursuing a psilocybin journey, you don't need to become an expert in psychedelics. You need to keep doing what you're already doing: providing a stable, supportive relationship in which difficult material can be explored and meaningful change can take root. That relationship may be the most important factor in whether your client's journey leads to lasting benefit.

I'm happy to discuss any of this further. If you have questions about working with a client who's considering psilocybin—or about a client who's already scheduled a journey—feel free to reach out by phone or Zoom. This work is new enough that we're all still learning, and I find conversations with thoughtful clinicians genuinely valuable.

Michael Kelly is a licensed psilocybin facilitator in Oregon and founder of Mindstream Wellness. He works within a psychological flexibility framework drawn from Acceptance and Commitment Therapy and maintains a longtime contemplative practice.

For more information or to schedule a conversation: 503-512-0729 or michaelk@mindstreamwellness.net